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Background and purpose: Malnutrition is a common problem in patients who are hospitalized in surgical and
medical wards. Surgical patients, geriatric populations and individuals with severe illness are more vulnerable to
malnutrition during their hospitalization course.
The purpose of this study was evaluation of parenteral nutrition services in a referral teaching hospital, Tehran, Iran.
Method: Medical records of 72 patients who received parenteral nutrition during one year period in different
surgical and medical wards of Imam Khomeini hospital were reviewed retrospectively by clinical pharmacists.
Criteria for initiation of parenteral nutrition, selection of appropriate formulation and monitoring parameters were
assessed based on the American Society of Parenteral and Enteral Nutrition recommendations.
Results: Based on the patients’ anthropometric parameters and serum albumin levels, 4.2%, 75% and 20.8% of the
patients were well-nourished, moderately malnourished and severely malnourished respectively at the hospital
admission and before nutritional support. Adequate calorie, protein, carbohydrate and lipid supports were achieved
in 21.1%, 32.4%, 23.7% and 10.5% of the patients respectively. About 91% of the patients experienced at least one
complication of the nutritional support.
Conclusion: In this evaluation, several errors in assessment, establishing goals, and monitoring of parenteral
nutrition regimens have been detected. Approximately all of the patients did not receive to the trace elements
supports goals.
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Malnutrition is a common problem in hospitalized
patients [1,2]. Surgical patients with malnutrition have
around three times more postoperative complications
and four times greater risk of death than well nourished
patients with similar operations [3]. Metabolic support
via parenteral nutrition (PN) has become an important
intervention in a variety of medical and surgical condi-
tions [4,5]. Although PN has improved patient
outcomes, recent meta-analysis have raised questions
about its safety and high rate of PN-associated complica-
tions [6]. Metabolic disturbances such as hyperglycemia,* Correspondence: khalilih@tums.ac.ir
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reproduction in any medium, provided the orelectrolyte abnormalities such as hypophosphatemia
or hypokalemia, infection of PN catheters, liver dys-
function (presented as steatosis, steatohepatitis, cho-
lestasis and cholelithiasis) and embolic events can
occur following PN [5,7-10]. Re-feeding syndrome is a
common and potentially dangerous metabolic compli-
cation of PN that can cause fatal cardiac arrhythmia,
systolic heart failure, respiratory insufficiency, and
hematologic derangements [11].
PN formulations are extremely complex admixtures
and errors in PN can occur in selection of appropriate
formulation, dose, administration method, labeling and
compounding devices [12-15]. For prevention of these
errors, appropriate evaluation of patient’s metabolic
needs, ordering, preparation, administration and moni-
toring of PN is essential. Nutritional support team isLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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metabolic needs, selecting appropriate route of nutri-
tional support, ordering patient’s specific admixture, and
patient’s monitoring for efficiency and complication of
nutritional support [16-18]. The purpose of this study
was evaluation of PN services in the surgical and med-
ical wards of a referral teaching hospital, Tehran, Iran.
Methods
Medical records of 72 patients who received PN in the
surgical and medical wards of Imam Khomeini Hospital
were reviewed retrospectively by clinical pharmacists
during one year period. The Institutional Review Board
(IRB) and the Medical Ethics Committee of the hospital
approved the study.
Patients’ nutritional assessment prior to initiation of
PN, daily PN formula, and monitoring parameters were
extracted from the patients’ medical charts. Criteria for
initiation of PN, selection of appropriate formulation
and monitoring parameters were assessed based on the
American Society of Parenteral and Enteral Nutrition
(ASPEN) recommendations [4]. These recommendations
have been summarized in Table 1 [3]. Nutritional sup-
port was considered appropriate if the patient had
received 90% of the recommended goals.
Statistical Package for the Social Sciences (SPSS) ver-
sion 11.5 (SPSS Inc., USA) was used for descriptive stat-
istical analysis. Categorical variables were expressed as
percentage. Continuous data were reported as mean ±
standard deviation (SD). Pair sample t-test was used for
comparison of patients’ laboratory parameters before
and after initiation of PN. Pearson chi-square was used
for evaluation of correlations.
Results
Seventy- two patients (43 males and 29 females) received
PN during one year period in the surgical and medical
wards of Imam Khomeini hospital. The patients were
under nutritional support only from PN (total parenteral
nutrition; TPN) route. Average age of the patients was
57.3±16.6 years old. Gastrointestinal surgeries (52.8%),
tumor resection surgeries (27.1%) were the most com-
mon reasons of the patients’ hospital admission followed
by cardiac (8.6%) and renal (7.1%) disorders. Most of the
patients were admitted in the surgical wards (73.6%).
The most common baseline diseases of the patients have
been shown in Table 2. Forty-eight (66.7%) and 24
(33.3%) of the patients received their PN supports
through a central venous catheter and peripheral venous
catheter respectively. Average length of the patients’
hospitalization and duration of PN were 21.3±11.0 and
11.7±7.8 days respectively.
Based on the anthropometric parameters (weight,
high, age, sex and body mass index) and patients’ serumalbumin levels, 4.2%, 75% and 20.8% of the patients were
well-nourished, moderately malnourished and severely
malnourished respectively at hospital admission and be-
fore PN initiation.
Average basal total energy expenditure, carbohydrate,
protein and lipid requirements and intakes of the
patients have been shown in Table 3. Sufficient energy,
protein, carbohydrate and lipid support were met in
21.1%, 32.4%, 23.7% and 10.5% of the patients respect-
ively. Patients’ mortality rates were not significantly dif-
ferent between the patients with sufficient or insufficient
metabolic support (p =0.7).
The mean volume of fluids that had administered for
the patients was 3571.2±986.1 ml which was sufficient
for 77.8% of the patients. Normal saline 0.9% (37%), dex-
trose water 10% (34%) and half saline (29%) were the
most used fluids. Average intakes and adequacy of elec-
trolytes support in the patients were reviewed in Table 4.
There were no significant differences between the
patients’ serum calcium (p =0.7), magnesium (p =0.6)
and phosphorus (p =0.7) concentrations before and after
PN (Table 5). Although the mean of patients’ serum al-
bumin levels was elevated after PN but it was insignifi-
cant (p =0.2). The patients received 43.9±37.1 ml of the
human albumin (20%) for mean duration of 12.9±8.3
days. The most common albumin indications in our
patients were hypovolemia (16.6%), edema (7.2%) and
cirrhosis (5.8%). In 76.7% of the patients who received
albumin during PN period, did not had the FDA
approved indications. Mortality rate in the patients who
received albumin with approved indications was signifi-
cantly less than those without indication (p =0.003).
All of the patients who vitamins were selected as a
component of their PN regimen, received more than the
recommended amounts of vitamin A, D, E and B12. Only
13.15% and 15.8% of them received vitamin K and B-
complex in appropriate doses respectively. They also
received vitamin C significantly more than their require-
ments (p =0.003).
We have also evaluated adequacy of PN monitoring in
the patients. The results have been shown in Table 6.
About 91% of the patients experienced at least one com-
plication of the nutritional supports (Table 7). The mean
blood sugar of the patients before PN was 109.3±29.4
mg/dl. Hyperglycemia occurred in 23.2% of the patients
as a complication of PN. Incidence of hyponatremia,
hypomagnesemia and hypokalemia were 16.6%, 10.5%
and 24.5% respectively in our patients. Just 1.4% and
5.8% of the patients experienced elevation of serum hep-
atic transaminases (≥ 3 times upper limit normal) and
bilirubin concentrations respectively. There were no sig-
nificant differences between the patients’ serum urea and
creatinine levels before and after PN. From the included
patients, twelve (16.6%) of them died. We have not
Table 1 Recommended criteria for parenteral nutrition*
1. Assessment
A. Nutritional history
Medical & surgical history
Psychosocial history
Socioeconomic status




B. Physical examination (include anthropometrics)
C. Biochemical assessment & other monitoring parameters
Body weight
Serum electrolytes (sodium, potassium, calcium, magnesium,





Complete blood count (CBC)
Liver function tests (AST, ALT, alkaline phosphatase, bilirubin)
International normalized ratio (INR), prothrombin time
2. Establish nutritional goals
A. Therapeutic plan
1. Energy: total calories 20–30 kcal/kg/day
(hospitalized patient 20–25kcal/kg/day
moderate stress/ malnourished 25–30 kcal/kg/day
severe stress, critically ill 30–35 kcal/kg/day)
2. Protein: maintenance 0.8-1 g/kg/day
catabolic patients 1.2-2 g/g/day
chronic renal failure (renal replacement therapy)
1.2-1.5 g/kg/day
acute renal failure + catabolic 1.5-1.8 g/kg/day
3. Fat: 15–30% of non-protein calories intake (≤ 2.5 g/kg/day)
4. Carbohydrate: 70–85% of non-protein calories intake (≤7 g/kg/day)
B. Fluid: 30–40 ml/kg
C. Additives















Iron: not routinely added
3. Vitamins:
Vitamin A 3300 IU/day
Vitamin D 200 IU/day
Vitamin E 10 IU/day
Vitamin K 150 mcg/day
Vitamin C (ascorbic acid) 200 mg/day
Vitamin B12 (cyanocobalamin) 5 mcg/day
Vitamin B1 (thiamin) 6 mg/day
Vitamin B2 (riboflavin) 3.6 mg/day
Vitamin B3 (niacin) 40 mg/day
Vitamin pantothenic acid 15 mg/day
Vitamin B6 (pyridoxine) 6 mg/day
Biotin 60 mcg/day








Serum electrolytes (sodium, potassium, chloride, bicarbonate)
BUN, creatinine
Glucose








*These criteria are based on the American Society of Parenteral and Enteral
Nutrition recent recommendations. In this guideline baseline nutritional
assessment of patients based on the anthropometric parameters, nutritional
history, physical examinations, laboratory and biochemical parameters and
pre-existing diseases were recommended. Nutritional requirements including
calorie, carbohydrate, protein, lipid, vitamins and trace elements were
considered with respect to severity of patients’ illnesses and clinical status.
Monitoring parameters during nutritional support course have been shown in
the end of the table.
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*In this table baseline diseases of the patient have been shown. Most patients
who required nutrition support, suffered from cancer (especially
gastrointestinal one).
Table 4 Average intakes and adequacy of electrolytes












Sodium 50 2.6 97.37
Magnesium 27.12 55.3 44.7
Potassium 69.14 92.1 7.9
Calcium 6.52 47.4 52.6
*Average electrolytes intake of the patients were collected from the patients’
medical records and the administered solutions. Adequacy of the electrolytes
supports were determined based on the American Society of Parenteral and
Enteral Nutrition recommendations and patients’ clinical status and severity of
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tional support (calorie, protein, lipid, electrolyte and vita-
mins) and the patients’ mortality rate.baseline illnesses.
Table 5 Comparison of the patients’ serum electrolytes,
total protein, albumin, creatinine and urea levels before
and after parenteral nutrition*Discussion
The most common problem related to pharmaceutical
preparation of PN formulations is day-to-day changes of
patients’ nutritional requirements following changing in
their clinical and physiological conditions [16,19-21].
Improving the quality of patients’ metabolic supports
can be achieved with adequate nutritional assessment
using a standard protocol. This is especially important in
the settings such as a referral teaching hospital with high
prevalence of nutritional support complexities [22].
The ASPEN standards for nutritional support, recom-
mend that all patients who are candidate for PN should
undergo nutritional assessment at baseline before initi-
ation of metabolic support. Baseline nutritional assess-
ments include gathering of patients’ demographic data
such as age, gender, weight, height, nutritional history,
physical examinations including anthropometric infor-
mation, and biochemical parameters (Table 1). These
measurements can be used to differentiate between
acute and chronic malnutrition and calculation of
patients’ nutritional requirements [4]. These assessment
were done somewhat for most of the patients during
hospitalization course and had been recorded in their
medical charts.
Based on the patients’ baseline nutritional assessment,
a metabolic support’s plan for fluids, calories, protein,Table 3 Average basal energy expenditure and other






Basal energy (kcal/day) 1844.2±345.1 1045.1±457.8 <0.001
Protein (g/day) 92.5±20.1 61.1±26.9 <0.001
Carbohydrate (g/day) 308.1±108.4 173.6±17.3 <0.001
Lipid (g/day) 513.1±748.7 496.1±76.5 0.9
*Basal energy, protein, carbohydrate, and lipid requirements of the patients
were calculated based on the American Society of Parenteral and Enteral
Nutrition recommendations and patients’ clinical status and severity of the
baseline illnesses. Amount of the patients’ intake were calculated based on the
administered solutions that had been recorded in the patients’ medical charts.fat, and carbohydrate should be designed for each pa-
tient [14]. We have used ASPEN criteria for evaluation
of PN in the study. Approximately 21.1% of the patients
received calorie goals, but we have not found any signifi-
cant correlation between the patients’ calorie intake and
mortality. However sample size of the study was too
small for evaluation of correlations between the para-
meters. Eighty percent of the patients received sufficient
fluid (volume) and it seems that low calorie intake was
not due to inadequate intake of volume.
Electrolytes, vitamins, minerals and other trace ele-
ments are necessary component of PN and metabolic
complications can arise following inappropriate replace-
ment of these nutrients [14,21]. From these elements,
calcium was frequently replaced inappropriately for the
patients. Sufficient calcium replacement is necessary as
there is a significant urine calcium loss in patients who
receiving PN [13,18].
Errors in replacement of vitamins were more frequent
in the study and most of the patients did not receive nu-







Calcium (mg/dl) 8.3±0.9 8.3±1.1 0.7
Magnesium (mg/dl) 2.3±0.5 2.2±0.4 0.6
Phosphorus (mg/dl) 2.9±0.9 2.9±1.1 0.7
Albumin (g/dl) 3.3±0.7 3.4±0.7 0.2
Protein (g/dl) 6.3±1.1 6.4±1.2 0.5
Urea (mg/dl) 53.2±47.3 50.3±47.2 0.3
Creatinine (mg/dl) 1.4±1.1 1.4±1.2 0.9
*The patients’ laboratory and biochemical parameters before and after
parenteral nutrition support were collected from the medical records and were
compared with paired sample t-test analysis.
Table 6 Accuracy of parenteral nutrition monitoring in the patients*
Parameter Correct monitoring (%) Errors in monitoring (%)
Daily monitoring parameters (such as temperature, patient’s intake and output) 13.2 86.8
CBC monitoring (semiweekly monitoring parameter) 81.6 18.4
Calcium, magnesium & phosphorus (semiweekly monitoring parameter) 21.1 78.9
Albumin (weekly monitoring parameter) 23.7 76.3
Liver function tests (weekly monitoring parameter) 39.5 60.5
*Accuracy of parenteral nutrition monitoring were determined based on the American Society of Parenteral and Enteral Nutrition recommendations and patients’
clinical status and severity of baseline illnesses.
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other human subjects. Metabolic complications such as
hypocalcemia, hypercalciuria and negative calcium bal-
ance have been reported following long-term PN [23,24].
Most of the patients received vitamin D more than their
requirement, probably due to availability of one paren-
teral vitamin D preparation (300,000 IU) in our hospitals
which contain more than even one week requirement of
a patient.
Vitamin K (as phylloquinone or menaquinones) is an
essential cofactor for coagulation cascade. Moreover,
there are some evidences that show roles of vitamin K in
the bone and vascular health. However the only gener-
ally accepted indication in the PN regimens is preven-
tion of bleeding. The natural phylloquinone content of
commercial PN products varies extensively depending
on their fat sources. High levels of this element were
reported in the PN formulations with soybean oil (150–
300 μg per 100 g) fat origin [25]. In year 2000, the US
Food and Drug Administration (FDA) organization
revised their guidelines and recommend that adult par-
enteral multivitamin preparations should supply 150 μg
phylloquinone per day [26]. In our study most of the
patients did not receive vitamin K in their PN regimen.
Baseline laboratory and biochemical parameters should
be assessed prior to initiation of PN. These parameters
were assessed appropriately in 60% of the patients. Ex-








Rise of liver function tests (%) 7.2
Catheter infection (%) 2.7
* Parenteral nutrition complications were detected based on the patients’
physical examinations, clinical evaluations, and monitoring of laboratory and
biochemical parameters.calcium and magnesium were not evaluated at baseline
for 89% of the patients. Vital signs (temperature, blood
pressure, respiratory rate, pulse rate), weight, and fluid
input and output, serum electrolytes (sodium, potassium,
chloride, bicarbonate), BUN, serum creatinine and blood
glucose are recommended to be monitored daily. In more
than 80% of the patients these parameters were moni-
tored semiweekly. It may be related to limited laboratory
facilities, nursing staff workload, and patient’s prefer-
ences [16,27].
Complete blood count monitoring was performed
semiweekly in most of the patients, but serum electro-
lytes levels were not monitored appropriately in more
than 70% of the patients. Serum albumin levels and hep-
atic enzymes that are recommended to be monitored as
weekly intervals were assessed more frequently in
35% of the patients. In another study conducted by
Macfarlane et al. the same results were obtained [16].
These differences may somewhat related to the recom-
mendations. For example monitoring of these parameters
as daily for 2 to 3 days, then every other day for 4 days,
and then every week was recommended by another guide-
line [28]. ASPEN guidelines recommend the weekly moni-
toring of these values as it is simple, less expensive and
requires less-frequent blood sampling. This criterion
should be changed if patient’s clinical condition needs
close monitoring [4,16].
In this evaluation, we have found several deficiencies in
assessment, establishing goals, and monitoring of the PN
regimens in the medical and surgical wards. Complete
nutritional assessments were performed only for 11% of
the patients and many of them did not receive nutritional
goals. About 25% of the patients received sufficient cal-
orie and protein. Due to cost and availability issues of the
parenteral trace elements products, approximately all of
the patients did not receive their requirements.
This study has some limitations that must be consid-
ered. First, the data cannot be generalized to other teach-
ing hospitals because of their different settings. Second,
the study was retrospective and other factors such as
exact nutrition status of the patients and effects of the
patients’ demographic data such as socio-economic sta-
tus were not evaluated. Small sample size is another
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patients for consequence of adequate or inadequate of
the nutritional support.
Conclusion
Errors in nutritional support processes, especially in era
of PN are common in the medical and surgical wards.
Development of an internal PN protocol for each hos-
pital under observation and monitoring of a nutritional
support team consisted of a physician, dietitian, pharma-
cist and nurse can prevent these errors. Education of
hospital staff about appropriate patient’s nutritional as-
sessment at hospital admission, ordering, and adminis-
tration of PN solutions are also helpful.
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